Home Opinions Market Stories
The SEQUENCE trial results showing better responses to risankizumab compared with ustekinumab in Crohn's patients who failed TNF inhibitor therapy may not be correct but highly impressive for a trial
“Recent Developments in Crohn′s Disease | MedPage Today - Medpage Today”

Health Opinion Screenshot
Show some love. Gift @thestephen something as TIPs
2 460 NGA
31 shares

MindViewers is where you meet and gist with interesting people, while you get paid online for simple activities.
Comments
Please Login or Signup to react
OR
From
To
Load comments
Other Opinions Of Mon, 1st Apr. 2024
Login To Enjoy Full Access
MindViewers Icon
  • Daily login bonus: withdraw to bank or airtime.
  • Meet intelligent people; sharpen your intellect.
  • Exchange interesting opinions about current headlines.
  • List your expertise and get patronages.
  • Read Stories: people's daily gists and experiences.
| | | | | | Statistics | Advertise | About | Terms | Privacy